Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia 27Lymphoma 25Lymphoma, Non-Hodgkin 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Myelodysplastic Syndromes 21Multiple Myeloma 21Leukemia, Myeloid, Acute 21Hodgkin Disease 16Leukemia, Lymphocytic, Chronic, B-Cell 15Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12Hematologic Neoplasms 10Neuroblastoma 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Graft vs Host Disease 6Neoplasms, Plasma Cell 5Leukemia, Myelomonocytic, Juvenile 5Breast Neoplasms 5Hemoglobinuria, Paroxysmal 4Rhabdoid Tumor 3Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma, B-Cell 3Leukemia, Myeloid, Accelerated Phase 3Ganglioneuroblastoma 3Blast Crisis 3Anemia, Refractory, with Excess of Blasts 3Anemia, Aplastic 3Wilms Tumor 2Recurrence 2

Interventions

Etoposide 22Carboplatin 22Filgrastim 17Ifosfamide 15Cisplatin 14Peripheral Blood Stem Cell Transplantation 12Paclitaxel 12Cyclophosphamide 9Bleomycin 9Thiotepa 5Radiotherapy 5Therapeutics 4Temozolomide 4Psychiatric Rehabilitation 4Oxaliplatin 4Melphalan 4Granulocyte Colony-Stimulating Factor 4Gemcitabine 4sargramostim 3pegfilgrastim 3etoposide phosphate 3Methylprednisolone 3Dexamethasone 3Busulfan 3liposomal amphotericin B 2ixabepilone 2aldesleukin 2aflibercept 2Trastuzumab 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Testicular Neoplasms × Stem Cell Transplantation × Clear all
NCT00936936 2024-08-26

High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors

M.D. Anderson Cancer Center

Phase 2 Completed
64 enrolled 10 charts
Genitourinary

Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡